Sermorelin Acetate + NAD+: A Longevity Strategy for Menopause, Andropause, and Metabolic Health


About the Author

Dr. Corina Ianculovici, DNP, FAAMFM, ABAAM-HP, is a board-certified advanced practice clinician specializing in

longevity medicine, metabolic health, and hormone optimization and functional aesthetics.

She is the founder of Mirelle Institute for Anti-Aging Medicine in New Jersey.


How Peptide Therapy, Cellular Energy Support, and Hormone Optimization Work Together to Support Healthy Aging

Aging is not simply the passage of time. It is a gradual shift in cellular signaling, metabolic efficiency, hormonal balance, and tissue regeneration.
Modern longevity medicine focuses on restoring these biological systems rather than treating isolated symptoms.

At Mirelle Institute for Anti-Aging Medicine, one of the most promising clinical strategies for supporting metabolic and hormonal health involves a carefully designed Sermorelin Acetate and NAD+ therapy stack.

When used as part of a clinician-guided program, these therapies may help support:
  • healthy body composition
  • preservation of lean muscle mass
  • metabolic resilience
  • cellular energy production
  • recovery and vitality
For many patients navigating menopause or andropause, this strategy is combined with bioidentical hormone replacement therapy (BHRT) and the 
Luxe Metabolic Reset program using GLP-1/GIP metabolic therapy.

Together, these therapies target several of the biological drivers of aging.

Understanding Peptides in Longevity Medicine

Peptides are short chains of amino acids that act as biological messengers within the body. They help regulate many essential physiological processes, including hormone release, tissue repair, and metabolism.

As we age, the efficiency of many signaling pathways declines. Longevity medicine seeks to restore these signaling networks using targeted therapies. Some peptides work by stimulating the body's natural hormone production pathways rather than replacing hormones directly.

One of the most widely used peptides in this category is Sermorelin Acetate.

What Is Sermorelin Acetate?

Sermorelin acetate is a synthetic analog of growth hormone–releasing hormone (GHRH). It works by stimulating the pituitary gland to release endogenous growth hormone (GH). Unlike direct growth hormone therapy, sermorelin activates the body's natural pulsatile GH secretion, which may help maintain more physiologic hormonal regulation.

Research has demonstrated that GHRH analog therapy can activate the somatotropic axis, the hormonal system involving growth hormone and IGF-1 that plays a role in metabolism, tissue repair, and body composition.

In a placebo-controlled clinical study of older adults, nightly administration of a GHRH analog increased lean body mass, skin thickness, insulin sensitivity, libido, and general well-being in men, while activating the growth hormone axis in both sexes (Veldhuis et al., Journal of Clinical Endocrinology & Metabolism).

Growth hormone signaling naturally declines with age. This decline is associated with:
  1. increased body fat
  2. reduced lean muscle mass
  3. decreased physical performance
Understanding and supporting this hormonal pathway is one of the goals of longevity medicine (Molitch ME, Endotext: Growth Hormone and Aging).

The Role of NAD+ in Cellular Energy and Aging

While Sermorelin targets hormonal signaling, NAD+ therapy focuses on cellular energy metabolism. NAD+ (nicotinamide adenine dinucleotide) is a critical coenzyme involved in many fundamental biological processes including:
  • mitochondrial energy production
  • DNA repair
  • oxidative stress response
  • metabolic regulation
  • sirtuin signaling pathways
Levels of NAD+ decline significantly with age, which may impair mitochondrial function and cellular resilience.

Research published in Cell Metabolism describes NAD+ as a key regulator of mitochondrial health and metabolic function (Rajman et al., 2018).

Because mitochondria produce the energy required for nearly every cellular process, therapies that support NAD+ pathways are being actively investigated in longevity medicine.

Why Combine Sermorelin and NAD+?

These two therapies work through complementary biological mechanisms.
  • Sermorelin supports hormonal signaling through the GH/IGF-1 pathway.
  • NAD+ supports mitochondrial energy production and cellular repair mechanisms.
Together, they target two central aspects of aging biology:
  • Declining endocrine signaling
  • Declining cellular energy production
When combined with proper nutrition, strength training, and sleep optimization, this approach may help support:
  1. metabolic resilience
  2. recovery and vitality
  3. healthy body composition
  4. improved cellular function

Body Composition, Visceral Fat, and Healthy Aging

Longevity medicine places strong emphasis on body composition rather than weight alone. Visceral fat—fat stored around internal organs—is strongly associated with:
  • insulin resistance
  • cardiovascular disease
  • metabolic syndrome
  • systemic inflammation
At the same time, aging is associated with sarcopenia, the progressive loss of muscle mass and strength. Muscle tissue is essential for metabolic health, glucose regulation, and long-term physical independence (Cruz-Jentoft et al., Age and Ageing).

Preserving lean mass while improving metabolic efficiency is therefore a major focus of modern anti-aging medicine.

Why Sleep Is One of the Most Important Longevity Factors

Sleep plays a central role in metabolic and hormonal health. Growth hormone secretion is closely linked to slow-wave sleep, the deepest phase of restorative sleep. Disruptions in sleep architecture may impair hormonal balance, recovery, and metabolic regulation (Van Cauter & Plat, Sleep Medicine Reviews).

Poor sleep is also associated with:
  • increased obesity risk
  • insulin resistance
  • cardiovascular disease
  • impaired cognitive performance
Improving sleep quality is therefore one of the most powerful interventions for metabolic health (Tasali et al., Nature Reviews Endocrinology).

Supporting Men Through Andropause

Andropause refers to the gradual decline in testosterone levels that occurs in men with aging. Common symptoms include:
  • fatigue
  • reduced libido
  • increased abdominal fat
  • loss of muscle mass
  • decreased energy and motivation
For men with clinically confirmed testosterone deficiency, testosterone replacement therapy may be appropriate under physician supervision (Endocrine Society Clinical Practice Guidelines).

Peptide therapies such as Sermorelin may serve as adjunctive tools within a broader metabolic and hormonal optimization strategy.

Supporting Women Through Menopause

Menopause is a major hormonal transition characterized by declining estrogen and progesterone levels. Symptoms can include:
  • hot flashes
  • weight gain
  • sleep disturbances
  • fatigue
  • changes in body composition
Hormone therapy remains the most effective treatment for vasomotor symptoms and menopause-related sleep disruption, according to the Menopause Society position statement (2022).

Longevity medicine often combines hormone optimization with metabolic and cellular support therapies to help women maintain energy, metabolic health, and body composition during this transition.

Integrating Peptide Therapy with the Luxe Metabolic Reset (GLP-1/GIP Therapy)

At Mirelle Institute, many patients use peptide therapy alongside the Luxe Metabolic Reset, our clinician-supervised metabolic program i
ncorporating GLP-1/GIP therapies.

GLP-1-based medications improve metabolic health by:
  • reducing appetite
  • improving insulin sensitivity
  • promoting fat loss
Large clinical trials such as the SURPASS trial have demonstrated significant reductions in body weight and visceral adipose tissue with GLP-1/GIP therapies like tirzepatide (Frías et al., New England Journal of Medicine). However, substantial weight loss can also lead to loss of lean muscle mass.

This is why preserving muscle through nutrition, resistance training, hormonal optimization, and recovery-support therapies becomes critically important during weight loss programs.

The Mirelle Institute Longevity Approach

At Mirelle Institute for Anti-Aging Medicine, we practice a precision longevity approach. Each patient undergoes a comprehensive evaluation before any therapy is recommended. Personalized treatment plans may include:
  • Sermorelin peptide therapy
  • NAD+ cellular support therapy
  • Bioidentical hormone replacement therapy (BHRT)
  • GLP-1/GIP metabolic optimization
  • body composition analysis and muscle preservation strategies
  • sleep and recovery optimization
Patients can also explore treatment possibilities using our advanced AI tools:


These forward technologies allow patients to visualize personalized aesthetic and body-composition possibilities before beginning treatment.

Conclusion

Longevity medicine is evolving rapidly as research continues to uncover how hormonal signaling, mitochondrial health, metabolism, and recovery interact in the aging process.

While no single therapy can reverse aging, integrated strategies that support hormonal balance, metabolic health, cellular energy production, and body composition may help patients maintain vitality and resilience as they age.

At Mirelle Institute, our mission is simple: to help patients age healthier, stronger, and more confidently 
through science-driven, clinician-guided care.

References

Veldhuis JD et al. Growth hormone–releasing hormone administration in older adults. Journal of Clinical Endocrinology & Metabolism.
Molitch ME. Growth Hormone and Aging. Endotext.
Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules. Cell Metabolism. 2018.
Covarrubias AJ et al. NAD+ metabolism and aging. Nature Reviews Molecular Cell Biology. 2021.
Cruz-Jentoft AJ et al. Sarcopenia: European consensus definition. Age and Ageing.
Van Cauter E, Plat L. Physiology of growth hormone secretion during sleep. Sleep Medicine Reviews.
Tasali E et al. Sleep and metabolic health. Nature Reviews Endocrinology.
The Menopause Society Position Statement. 2022.
Endocrine Society Clinical Practice Guideline: Testosterone Therapy in Men.
Frías JP et al. Tirzepatide for Type 2 Diabetes. New England Journal of Medicine.